| James E Dillon, PHARMD | |
|
1300 E Bradford Pkwy Bldg A, Springfield, MO 65804-4294 | |
| (417) 761-5000 | |
| (417) 761-5011 |
| Full Name | James E Dillon |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1300 E Bradford Pkwy Bldg A, Springfield, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043897424 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 2020029154 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James E Dillon, PHARMD 1300 E Bradford Pkwy Bldg A, Springfield, MO 65804-4294 Ph: (417) 761-5000 | James E Dillon, PHARMD 1300 E Bradford Pkwy Bldg A, Springfield, MO 65804-4294 Ph: (417) 761-5000 |
News Archive
RPS Diagnostics, Inc. today announced CE mark of its FebriDx test, clearing the way for sales in the European Union and all countries recognizing the CE mark.
The United States Patent & Trademark Office issued a patent for an environmentally "Green" low cost process that eliminates the effects of a broad range of pollutants using oxidants.
High salaries and free food aren't enough any more in Silicon Valley, where maturing companies are competing for talent with creative health care and "wellness" programs that use gadgets to promote good behavior. Standard benefits at the largest technology companies, including Google Inc and Apple Inc, range from fertility treatments to deluxe on-site medical clinics, to new technology treats like health-tracking bracelets. The health largesse separates Silicon Valley's raging economy from many other sectors in the United States, but tech companies' experiments with perks show signs of spreading, benefits managers say.
A team of scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University has discovered why long-term treatment with many common antibiotics can cause harmful side effects-and they have uncovered two easy strategies that could help prevent these dangerous responses.
The experimental "smart-bomb" drug rovalpituzumab tesirine (Rova-T) appears safe and shows efficacy in treating patients with advanced small cell lung cancer (SCLC), according to results from a first-in-human clinical trial to be presented today by a Memorial Sloan Kettering Cancer Center researcher at the 2016 American Society of Clinical Oncology Annual Meeting in Chicago.
› Verified 3 days ago
Bryan E Strickland, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2640 E Sunshine St, Springfield, MO 65804 Phone: 417-885-1274 | |
Aline Najarian, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1525 W Kearney St, Springfield, MO 65803 Phone: 417-862-4099 | |
Montana Zitnak, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2825 N Kansas Expy, Springfield, MO 65803 Phone: 417-831-1000 | |
Mrs. Melody Ann Savley, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2650 W Kearney St, Springfield, MO 65803 Phone: 417-865-1547 Fax: 417-862-2571 | |
Chelsea Landgraf, PHARMD, BCPS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 S National Ave, Springfield, MO 65807 Phone: 417-576-8877 | |
Dr. Jill Andrea Sellers, BSPHARM, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3650 E Sunshine St, Springfield, MO 65809 Phone: 417-889-7898 | |
Dr. Austin Lovan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3800 S National Ave Fl 7, Springfield, MO 65807 Phone: 417-269-3807 |